Single Institution Experience with Nivolumab in Treatment of Patients with Relapsed or Refractory Hodgkin ’s Lymphoma

Nivolumab, Hodgkin ’s lymphoma.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Barbora Ka šperová, Miriam Ladická, Ľuboš Drgoňa, Radoslav Greksák, Ivona Bizikova, Ladislav Fekete, Martin Rázus, Andrej Vranovský Source Type: research